2-Chloro-5-hydroxyisonicotinic acid

Catalog No.: 
ACFEJY715
CAS No.: 
1060804-57-0
Molecular Formula: 
C6H4ClNO3
Molecular Weight: 
173.55
2-Chloro-5-hydroxyisonicotinic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$58.00In stockInquiry
250mg97%$82.00In stockIn stock
1g97%$167.00In stockIn stock
5g97%$515.00In stockInquiry
25g97%$2238.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-5-hydroxyisonicotinic acid
IUPAC Name2-chloro-5-hydroxyisonicotinic acid
MDL No.MFCD13189124
Molecular FormulaC6H4ClNO3
Molecular Weight173.55
SMILESO=C(O)C1=C(O)C=NC(Cl)=C1
InChI KeyHRQRNMNNTRITIK-UHFFFAOYSA-N
Synonym2-CHLORO-5-HYDROXYISONICOTINIC ACID | 1060804-57-0 | 2-chloro-5-hydroxypyridine-4-carboxylic acid | MFCD13189124 | SCHEMBL20855918 | DTXSID30693606 | 2-chloro-5-hydroxyisonicotinicacid | AKOS015995064 | AB67788 | CS-W006688 | DS-15806 | SY026953 | FT-0750479 | EN300-121428 | J-50884
CAS No.1060804-57-0
PubChem CID53350354

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFEJY715 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFEJY715 route product structure diagram
    ACFEJY7151060804-57-0In Stock
Inquiry

2. ACFEJY715 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFEJY715 route product structure diagram
    ACFEJY7151060804-57-0In Stock
Inquiry

3. ACFEJY715 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFEJY715 route product structure diagram
    ACFEJY7151060804-57-0In Stock
Inquiry

Comments (0)